Browse 721 respiratory clinical trials enrolling across the United States and Canada. 332 people applied to respiratory studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 721
National Vaccine Adverse Event Reporting Survey and Etiology
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
for
Pre-Bronchiolitis Obliterans Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Renovion, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05654922
Phase 3, Recruiting
POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test
for
COVID-19
Location: Modesto CA
Sponsor: Therma Bright Inc
Sex: All
Age: 12+
Code: NCT05119530
Recruiting
Comparing Intubation Rates in the Delivery Room by Interface
for
Ventilator Lung; Newborn
Location: Peoria IL
Sponsor: University of Illinois College of Medicine at Peoria
Sex: All
Age: 0
Code: NCT05609773
Recruiting
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
for
Pulmonary Disease, Postoperative Complications
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04164173
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Modafinil to Optimize the Performance of Cold-Stressed Sleep-Deprived Personnel
for
Sleep Deprivation, Cold Exposure
Location: Natick MA
Sponsor: United States Army Research Institute of Environmental Medicine
Sex: All
Age: 17 - 39
Code: NCT07830056
Recruiting
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
for
COVID -19, COVID-19 (Prevention)
Location: Austin TX, Las Vegas NV
Sponsor: ModeX Therapeutics, An OPKO Health Company
Sex: All
Age: 18 - 64
Code: NCT07445971
Phase 1, Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
for
SARS-CoV-2
Location: Richmond VA, Decatur GA, Atlanta GA, Gulfport MS,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT06585241
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Phase 4, Recruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research